EditorialKommentar
Nemolizumab reduces itch and improves other signs of atopic dermatitis in children aged 6–12 years
British Journal of Dermatology · 2023
DOI: 10.1093/bjd/ljad468 ↗Kurz gefasst
Editorial in der Zeitschrift British Journal of Dermatology, 2023. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Dermatitis, AtopicHumansChildDouble-Blind MethodPruritusAntibodies, Monoclonal, Humanized
Substanzen
nemolizumabAntibodies, Monoclonal, Humanized
Zitieren
APA
(2023). Nemolizumab reduces itch and improves other signs of atopic dermatitis in children aged 6–12 years. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad468
Vancouver
Nemolizumab reduces itch and improves other signs of atopic dermatitis in children aged 6–12 years. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljad468
BibTeX
@article{euvimed2023,
title = {Nemolizumab reduces itch and improves other signs of atopic dermatitis in children aged 6–12 years},
journal = {British Journal of Dermatology},
year = {2023},
doi = {10.1093/bjd/ljad468}
}
EUVIMED